3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
17
Stomach Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Rectal Neoplasms
5
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Nasopharyngeal Carcinoma
3
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Solid Tumor
2
Recurrence
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Resectable NSCLC
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Metastatic Gastroesophageal Junction Adenocarcinoma
1
Meningeal Carcinomatosis
1
MSI-H
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
pembrolizumab
136
Nivolumab
115
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
sintilimab
×
1 year
×
Clear all
No trials found.